In the World Health Summit (WHS) Regional Meeting Asia 2025, Piyush Goyal, Minister of Commerce & Industry criticized pharmaceutical companies for making their patent evergreen. The summit was held in Delhi’s Bharat Manda...
Dr. Reddy's Laboratories is preparing to enter the rapidly expanding GLP-1 (glucagon-like peptide-1) drug market, hoping to launch generic versions of key diabetes and obesity drugs such as Semaglutide...
The US FDA requests that Novavax finish a new clinical trial for the postponed COVID-19 vaccination. The WSJ reports According to persons familiar with the situation, the Wall Street Journal said Friday that federal
Amplitude Surgical SA (Amplitude) and Zydus Lifesciences Limited (Zydus) attest that Amplitude has consulted with Amplitude SAS's works council and provided the required information. As a result, Zydus has agreed to buy 75.4 percent
The Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization to Entod Pharmaceuticals, a multinational research-driven ophthalmic firm, for a novel ocular formulation designed
Prescription drugs that are often made or contain ingredients from China and India are stocked up in American households.
PCI Pharma Services ("PCI") – an award-winning global contract development and manufacturing company (CDMO) specializing in cutting-edge biopharma therapies – is buying a full equity interest in...
One of the biggest landmarks in the scientific advancement of India has been achieved through an innovative partnership between Bengaluru's Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem) of the Biotechnology Research and...
Syngene International has made a report stating that it has earned a total income of Rs.1036.9 for the period ended March 31, 2025. Leading to the company making a net profit of 183.3 crores for the same period. The company's financial year 20...
After reporting a 22.05 percent increase in consolidated net profit to Rs. 21.70 crore in Q4 FY25 over Q4 FY24, and a 21.34 percent increase in operating revenue to Rs. 187.16 crore, Thyrocare Technologies saw a 15 percent spike to Rs. 884.20.
, CDSCO.jpg)
